MA
KYNB

MUFG Americas’s Kyntra Bio KYNB Stock Holding History

MUFG Americas’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-21
Closed -$32K – 752
2018
Q3 		$32K Hold
21
– – ﹤0.01% 576
2018
Q2 		$33K Hold
21
– – ﹤0.01% 592
2018
Q1 		$24K Sell
21
-6
-22% -$7.9K ﹤0.01% 626
2017
Q4 		$33K Sell
27
-9
-25% -$11.3K ﹤0.01% 642
2017
Q3 		$49K Sell
36
-2
-5% -$2.11K ﹤0.01% 574
2017
Q2 		$31K Hold
38
– – ﹤0.01% 634
2017
Q1 		$23K Buy
38
+7
+23% +$4.26K ﹤0.01% 687
2016
Q4 		$17K Buy
31
+4
+15% +$2K ﹤0.01% 747
2016
Q3 		$14K Hold
27
– – ﹤0.01% 784
2016
Q2 		$11K Buy
27
+16
+145% +$7.33K ﹤0.01% 818
2016
Q1 		$6K Buy
+11
New +$5.48K ﹤0.01% 901
2015
Q4 		– Sell
-5
Closed -$3K – 1109
2015
Q3 		$3K Buy
+5
New +$3.03K ﹤0.01% 1043

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MUFG Americas's KYNB Position: Q4 2018 in Review

MUFG Americas sold out of Kyntra Bio (KYNB) in Q4 2018, closing a stake of 21 shares — an estimated $32K sold.

MUFG Americas first reported a position in KYNB in Q3 2015 and held it in 12 quarters. The position peaked at $49K in Q3 2017. 201 funds tracked by Wall St. Rank hold KYNB as of Q4 2018.

  • MUFG Americas reported no remaining Kyntra Bio position as of Q4 2018 after selling out during the quarter.
  • MUFG Americas sold 21 Kyntra Bio shares in Q4 2018, an estimated $32K.
  • MUFG Americas first reported a position in Kyntra Bio in Q3 2015 and held it in 12 quarters.
  • MUFG Americas's Kyntra Bio position peaked at $49K in Q3 2017.
  • 201 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2018.

Based on MUFG Americas's 13F filing for Q4 2018, filed 13 Feb 2019.